Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FS 120

Next Previous
Drug Profile

FS 120

Alternative Names: FS-120

Latest Information Update: 02 Jun 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator F-star
  • Developer F-star; F-star Beta; F-star Therapeutics
  • Class Antineoplastics; Bispecific antibodies; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action CD137 antigen agonists; OX40 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Cancer

Most Recent Events

  • 02 Jun 2026 FS 120 is still in Phase-I clinical trials in Cancer (Combination therapy, Late-stage disease, Metastatic disease, Monotherapy) in Spain, USA (IV) (NCT04648202)
  • 28 Apr 2025 No recent reports of development identified for phase-I development in Cancer(Late-stage disease, Metastatic disease, Monotherapy) in Spain (IV)
  • 28 Dec 2023 No recent reports of development identified for phase-I development in Cancer(Combination therapy, Late-stage disease, Metastatic disease) in USA (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top